-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Nanosyn Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substances. Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 9, 2020. Such persons may also file a written request for a hearing on the application on or before November 9, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on August 6, 2020, Nanosyn Inc., 3331 Industrial Drive, Suite B, Santa Rosa, California 95403-2062, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substances:
Controlled substance Drug code Schedule Oxymorphone 9652 II Fentanyl 9801 II The company is a contract manufacturer. At the request of the company's customers, it manufactures derivatives of controlled substances in bulk form.
Start SignatureWilliam T. McDermott,
Assistant Administrator.
[FR Doc. 2020-19868 Filed 9-8-20; 8:45 am]
BILLING CODE P
Document Information
- Published:
- 09/09/2020
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2020-19868
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 9, 2020. Such persons may also file a written request for a hearing on the application on or before November 9, 2020.
- Pages:
- 55689-55689 (1 pages)
- Docket Numbers:
- Docket No. DEA-704
- PDF File:
- 2020-19868.pdf